Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference | Financial Buzz

Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference

Tango Therapeutics Inc., a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, MD, President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a panel on synthetic lethality in cancer therapeutics at the 12th Annual Wedbush PacGrow Healthcare Conference on Tuesday, August 10 at 11:30 AM ET.

A live webcast of the event will be available under the “Events & Presentations” tab on the “Investors” page on the Company’s website on the day of the event. A replay of the webcast will be archived on the Company’s website for 30 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Contacts

Investor Contact:

Sam Martin

Argot Partners

tango@argotpartners.com

Media Contact:

Joshua R. Mansbach

Argot Partners

tango@argotpartners.com

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!